Viking Therapeutics (VKTX) Q2 2021 Earnings Call Transcript

Viking Therapeutics (VKTX) Q2 2021 Earnings Call Transcript


Operator
Welcome to the Viking Therapeutics' 2021 second-quarter financial results conference call. [Operator instructions] As a reminder, this conference call is being recorded today, July 28, 2021. I would now like to turn the conference over to Viking's manager of investor relations, Stephanie Diaz. Please go ahead, Stephanie.
Stephanie Diaz --
Manager of Investor Relations
Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's president and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution that comments made during this conference call today, July 28, 2021, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its development activities, time lines and milestones.

Related Keywords

, Raymond James , Joon Lee Truist , Greg Zante , Steven Seedhouse Raymond James , Steven Seedhouse , Matthew Luchini , Joon Lee , Stephanie Diaz , Exchange Commission , International Liver Congress , Viking Therapeutics , Viking Therapeutic , Brian Lian , Securities Litigation Reform Act , Chief Executive , ரேமஂட் ஜேம்ஸ் , கிரெக் ஜந்தே , ஜூன் லீ , மாற்றாந்தாய் டியாஸ் , பரிமாற்றம் தரகு , சர்வதேச கல்லீரல் காங்கிரஸ் , வைக்கிங் சிகிச்சை , பிரையன் லியன் , பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , தலைமை நிர்வாகி ,

© 2025 Vimarsana